Jennifer R. Stephens

Therapeutic Inhibition of MAP Kinase Interacting Kinase Blocks Eukaryotic Initiation Factor 4E Phosphorylation and Suppresses Outgrowth of Experimental Lung Metastases

Bruce W. Konicek, Jennifer R. Stephens, Ann M. McNulty et al. · Cancer Research · 2011 · 187 citations · Full text

Bioavailable Mnk Inhibitor, Cancer Biology, Tumor Biology +21

LY2875358, a Neutralizing and Internalizing Anti-MET Bivalent Antibody, Inhibits HGF-Dependent and HGF-Independent MET Activation and Tumor Growth

Ling Liu, Wei Zeng, Mark A. Wortinger et al. · Clinical Cancer Research · 2014 · 105 citations

Pirtobrutinib preclinical characterization: a highly selective, non-covalent (reversible) BTK inhibitor

Eliana B Gómez, Kevin Ebata, Hetal S Randeria et al. · Blood · 2023 · 84 citations · Full text

Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models

Caitlin D. Lowery, Michele Dowless, Matthew Renschler et al. · Clinical Cancer Research · 2018 · 79 citations · Full text

LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer

Eliza Vakana, Susan E. Pratt, Wayne Blosser et al. · Oncotarget · 2016 · 66 citations · Full text

Pathology, Cancer Biology, Tumor Biology +16